André T - Search Results

1

Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.

Cohen R, Taieb J, Fiskum J, Yothers G, Goldberg R, Yoshino T, Alberts S, Allegra C, de Gramont A, Seitz JF, O'Connell M, Haller D, Wolmark N, Erlichman C, Zaniboni A, Lonardi S, Kerr R, Grothey A, Sinicrope FA, André T, Shi Q. Cohen R, et al. Among authors: andre t. J Clin Oncol. 2021 Feb 20;39(6):642-651. doi: 10.1200/JCO.20.01600. Epub 2020 Dec 23. J Clin Oncol. 2021. PMID: 33356421 Free PMC article.

2

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).

Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M. Beerblock K, et al. Among authors: andre t. Cancer. 1997 Mar 15;79(6):1100-5. Cancer. 1997. PMID: 9070486 Clinical Trial.

3

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.

de Gramont A, Vignoud J, Tournigand C, Louvet C, André T, Varette C, Raymond E, Moreau S, Le Bail N, Krulik M. de Gramont A, et al. Among authors: andre t. Eur J Cancer. 1997 Feb;33(2):214-9. doi: 10.1016/s0959-8049(96)00370-x. Eur J Cancer. 1997. PMID: 9135491 Clinical Trial.

4

[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].

de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Molitor JL, Krulik M. de Gramont A, et al. Among authors: andre t. Rev Med Interne. 1997;18 Suppl 4:372s-378s. doi: 10.1016/s0248-8663(97)83768-x. Rev Med Interne. 1997. PMID: 9365715 Review. French.

5

[Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD].

de Gramont A, Tournigand C, Louvet C, André T, Molitor JL, Raymond E, Moreau S, Vignoud J, Le Bail N, Krulik M. de Gramont A, et al. Among authors: andre t. Rev Med Interne. 1997;18(10):769-75. doi: 10.1016/s0248-8663(97)89966-3. Rev Med Interne. 1997. PMID: 9500010 Clinical Trial. French.

6

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).

de Gramont A, Louvet C, André T, Tournigand C, Krulik M. de Gramont A, et al. Among authors: andre t. Eur J Cancer. 1998 Apr;34(5):619-26. doi: 10.1016/s0959-8049(97)00364-x. Eur J Cancer. 1998. PMID: 9713264 Review.

7

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

André T, Louvet C, Raymond E, Tournigand C, de Gramont A. André T, et al. Ann Oncol. 1998 Nov;9(11):1251-3. doi: 10.1023/a:1008475122124. Ann Oncol. 1998. PMID: 9862058 Free article. Clinical Trial.

8

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.

André T, Bensmaine MA, Louvet C, François E, Lucas V, Desseigne F, Beerblock K, Bouché O, Carola E, Merrouche Y, Morvan F, Dupont-André G, de Gramont A. André T, et al. J Clin Oncol. 1999 Nov;17(11):3560-8. doi: 10.1200/JCO.1999.17.11.3560. J Clin Oncol. 1999. PMID: 10550155 Clinical Trial.

9

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

Maindrault-Goebel F, Louvet C, André T, Carola E, Lotz JP, Molitor JL, Garcia ML, Gilles-Amar V, Izrael V, Krulik M, de Gramont A. Maindrault-Goebel F, et al. Among authors: andre t. Eur J Cancer. 1999 Sep;35(9):1338-42. doi: 10.1016/s0959-8049(99)00149-5. Eur J Cancer. 1999. PMID: 10658524 Clinical Trial.

10

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.

André T, Balosso J, Louvet C, Hannoun L, Houry S, Huguier M, Colonna M, Lotz JP, De Gramont A, Bellaïche A, Parc R, Touboul E, Izrael V. André T, et al. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):903-11. doi: 10.1016/s0360-3016(99)00478-2. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

529 results

Search Page